Foresite Capital Management III as of Sept. 30, 2020
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 10 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Myokardia | 40.5 | $54M | 399k | 136.33 | |
| Natera (NTRA) | 11.2 | $15M | 209k | 72.24 | |
| Oric Pharmaceuticals | 9.3 | $12M | 497k | 25.01 | |
| Acceleron Pharma | 9.1 | $12M | 109k | 112.53 | |
| Epizyme | 8.9 | $12M | 998k | 11.93 | |
| Cymabay Therapeutics | 8.9 | $12M | 1.6M | 7.24 | |
| Fibrogen (FGEN) | 5.3 | $7.1M | 173k | 41.12 | |
| Verona Pharma Spons Ads (VRNA) | 5.2 | $6.9M | 1.1M | 6.24 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $1.8M | 685k | 2.57 | |
| Novavax (NVAX) | 0.4 | $542k | 5.0k | 108.40 |
